Skip to main content

DI011

WHO Product ID
DI011
Status
Prequalified
INN, dosage form and strength
Zinc (sulfate) Tablet, Dispersible 20mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
Diarrhoea
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Dispersible
Applicant organization
Ipca Laboratories Ltd
48 Kandivli Industrial Estate, Kandivli (West)
Mumbai,
Maharashtra
400 067
India
Packaging details and storage conditions
Packaging Type
Blister, Alu/PVDC/PVC
Configuration
10x1, 10x3, 10x10
Shelf life (months)
48
Packaging Type
Blister, Alu/Alu
Configuration
10x1, 10x3, 10x10
Shelf life (months)
48
API Manufacturing Site(s)
By Organization
By Active Ingredient
Canton Laboratories Pvt Ltd
Survey No. 350, Mujpur, Vadodara
Taluka: Padra,
Gujarat
391440
India
Zinc (sulfate)
FPP Manufacturing Site(s)
Ipca Laboratories Ltd
Plot No 255/1, Village Athal
Silvassa 396230,
Dadra and Nagar Haveli
and Daman and Diu
India
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorised for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , Part 4 , Part 5 , Part 6 , Part 7 , Part 8

.